Mumbai, Aug. 7 -- Zydus Lifesciences (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg. This is the group's first NOC approval in Canada.

Published by HT Digital Content Services with permission from Capital Market....